ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria [Carta] (2023)
Gurnari, Carmelo; Prata, Pedro Henrique de Lima; Catto, Luiz Fernando Bazzo ; Durmaz, Arda; Pinto, André Luiz; Inacio, Mariana Carolina Beraldo; Hernandez, Lucie; Dhedin, Nathalie; Visconte, Valeria; Soulier, Jean; Calado, Rodrigo Tocantins
Source: Blood. Unidade: FMRP
Subjects: ANEMIA, NEOPLASIAS, DOENÇAS RARAS, LEUCEMIA MIELOIDE AGUDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GURNARI, Carmelo et al. IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria [Carta]. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood.2023020108. Acesso em: 18 nov. 2024. , 2023
APA
Gurnari, C., Prata, P. H. de L., Catto, L. F. B., Durmaz, A., Pinto, A. L., Inacio, M. C. B., et al. (2023). IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria [Carta]. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood.2023020108
NLM
Gurnari C, Prata PH de L, Catto LFB, Durmaz A, Pinto AL, Inacio MCB, Hernandez L, Dhedin N, Visconte V, Soulier J, Calado RT. IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria [Carta] [Internet]. Blood. 2023 ; 141( 25): 3122-3125.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1182/blood.2023020108
Vancouver
Gurnari C, Prata PH de L, Catto LFB, Durmaz A, Pinto AL, Inacio MCB, Hernandez L, Dhedin N, Visconte V, Soulier J, Calado RT. IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria [Carta] [Internet]. Blood. 2023 ; 141( 25): 3122-3125.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1182/blood.2023020108
Artigo de periodico
Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT (2023)
Gurnari, Carmelo; Robin, Marie; Godley, Lucy A.; Onida, Francesco; Ciceri, Fabio; Bonfim, Carmem; Makishima, Hideki; Hamad, Nada; Voso, Maria Teresa; Mecucci, Cristina; Duarte, Fernando Barroso; Sebert, Marie; Calado, Rodrigo Tocantins
Source: The Lancet Haematology. Unidade: FMRP
Subjects: PREDISPOSIÇÃO GENÉTICA PARA DOENÇA, DOENÇA ENXERTO-HOSPEDEIRO, CÉLULAS-TRONCO, NEOPLASIAS, TRANSPLANTE HOMÓLOGO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GURNARI, Carmelo et al. Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT. The Lancet Haematology, v. 10, n. 12, p. e994-e1005, 2023Tradução . . Disponível em: https://doi.org/10.1016/S2352-3026(23)00265-X. Acesso em: 18 nov. 2024.
APA
Gurnari, C., Robin, M., Godley, L. A., Onida, F., Ciceri, F., Bonfim, C., et al. (2023). Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT. The Lancet Haematology, 10( 12), e994-e1005. doi:10.1016/S2352-3026(23)00265-X
NLM
Gurnari C, Robin M, Godley LA, Onida F, Ciceri F, Bonfim C, Makishima H, Hamad N, Voso MT, Mecucci C, Duarte FB, Sebert M, Calado RT. Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT [Internet]. The Lancet Haematology. 2023 ; 10( 12): e994-e1005.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/S2352-3026(23)00265-X
Vancouver
Gurnari C, Robin M, Godley LA, Onida F, Ciceri F, Bonfim C, Makishima H, Hamad N, Voso MT, Mecucci C, Duarte FB, Sebert M, Calado RT. Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT [Internet]. The Lancet Haematology. 2023 ; 10( 12): e994-e1005.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/S2352-3026(23)00265-X
Artigo de periodico
Hippo pathway-related genes expression is deregulated in myeloproliferative neoplasms (2022)
Cacemiro, Maira da Costa ; Cominal, Juçara Gastaldi ; Pereira, Luiz Miguel ; Berzoti-Coelho, Maria Gabriela ; Berbel, Giovana Michelassi; Baroni, Luciana ; Pereira, Tathiane Maistro Malta ; Tognon, Raquel; Nunes, Natália de Souza ; Souto, Elizabeth Xisto; Pontes, Lorena Lobo de Figueiredo ; Natsui, Ana Patrícia Yatsuda ; Castro, Fabíola Attié de
Source: Medical Oncology. Unidades: FCFRP, FMRP, ESALQ, FFCLRP, IQ
Subjects: APOPTOSE, EXPRESSÃO GÊNICA, HIPOTÁLAMO, NEOPLASIAS, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CACEMIRO, Maira da Costa et al. Hippo pathway-related genes expression is deregulated in myeloproliferative neoplasms. Medical Oncology, v. 39, n. 5, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1007/s12032-022-01696-x. Acesso em: 18 nov. 2024.
APA
Cacemiro, M. da C., Cominal, J. G., Pereira, L. M., Berzoti-Coelho, M. G., Berbel, G. M., Baroni, L., et al. (2022). Hippo pathway-related genes expression is deregulated in myeloproliferative neoplasms. Medical Oncology, 39( 5), 1-11. doi:10.1007/s12032-022-01696-x
NLM
Cacemiro M da C, Cominal JG, Pereira LM, Berzoti-Coelho MG, Berbel GM, Baroni L, Pereira TMM, Tognon R, Nunes N de S, Souto EX, Pontes LL de F, Natsui APY, Castro FA de. Hippo pathway-related genes expression is deregulated in myeloproliferative neoplasms [Internet]. Medical Oncology. 2022 ; 39( 5): 1-11.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s12032-022-01696-x
Vancouver
Cacemiro M da C, Cominal JG, Pereira LM, Berzoti-Coelho MG, Berbel GM, Baroni L, Pereira TMM, Tognon R, Nunes N de S, Souto EX, Pontes LL de F, Natsui APY, Castro FA de. Hippo pathway-related genes expression is deregulated in myeloproliferative neoplasms [Internet]. Medical Oncology. 2022 ; 39( 5): 1-11.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s12032-022-01696-x
Artigo de periodico
Philadelphia-negative myeloproliferative neoplasms display alterations in monocyte subpopulations frequency and immunophenotype (2022)
Bassan, Vitor Leonardo; Barretto, Gabriel Dessotti; Almeida, Felipe Campos de; Palma, Patricia Vianna Bonini; Binelli, Larissa Sarri; Silva, João Paulo Lettieri da; Fontanari, Caroline; Castro, Ricardo Cardoso; Pontes, Lorena Lobo de Fiqueiredo; Frantz, Fabiani Gai; Castro, Fabíola Attié de
Source: Medical Oncology. Unidades: FCFRP, FMRP
Subjects: NEOPLASIAS, MEDULA ÓSSEA, MONÓCITOS, INFLAMAÇÃO, CITOMETRIA DE FLUXO, FISIOPATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASSAN, Vitor Leonardo et al. Philadelphia-negative myeloproliferative neoplasms display alterations in monocyte subpopulations frequency and immunophenotype. Medical Oncology, v. 39, n. 12, p. 1-12, 2022Tradução . . Disponível em: https://doi.org/10.1007/s12032-022-01825-6. Acesso em: 18 nov. 2024.
APA
Bassan, V. L., Barretto, G. D., Almeida, F. C. de, Palma, P. V. B., Binelli, L. S., Silva, J. P. L. da, et al. (2022). Philadelphia-negative myeloproliferative neoplasms display alterations in monocyte subpopulations frequency and immunophenotype. Medical Oncology, 39( 12), 1-12. doi:10.1007/s12032-022-01825-6
NLM
Bassan VL, Barretto GD, Almeida FC de, Palma PVB, Binelli LS, Silva JPL da, Fontanari C, Castro RC, Pontes LL de F, Frantz FG, Castro FA de. Philadelphia-negative myeloproliferative neoplasms display alterations in monocyte subpopulations frequency and immunophenotype [Internet]. Medical Oncology. 2022 ; 39( 12): 1-12.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s12032-022-01825-6
Vancouver
Bassan VL, Barretto GD, Almeida FC de, Palma PVB, Binelli LS, Silva JPL da, Fontanari C, Castro RC, Pontes LL de F, Frantz FG, Castro FA de. Philadelphia-negative myeloproliferative neoplasms display alterations in monocyte subpopulations frequency and immunophenotype [Internet]. Medical Oncology. 2022 ; 39( 12): 1-12.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s12032-022-01825-6
Artigo de periodico
Personal positioning of oncology patients in palliative care: a mixed-methods study (2022)
Silva, Hellen Luiza Meireles; Valério, Pedro Henrique Martins; Barreira, Cristiano Roque Antunes ; Peria, Fernanda Maris
Source: BMC Palliative Care. Unidades: EEFERP, FMRP
Subjects: NEOPLASIAS, CUIDADOS PALIATIVOS, ESTUDOS TRANSVERSAIS, PESQUISA QUALITATIVA, QUALIDADE DE VIDA, FENOMENOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Hellen Luiza Meireles et al. Personal positioning of oncology patients in palliative care: a mixed-methods study. BMC Palliative Care, v. 21, n. 1, p. 1-13, 2022Tradução . . Disponível em: https://doi.org/10.1186/s12904-022-00916-5. Acesso em: 18 nov. 2024.
APA
Silva, H. L. M., Valério, P. H. M., Barreira, C. R. A., & Peria, F. M. (2022). Personal positioning of oncology patients in palliative care: a mixed-methods study. BMC Palliative Care, 21( 1), 1-13. doi:10.1186/s12904-022-00916-5
NLM
Silva HLM, Valério PHM, Barreira CRA, Peria FM. Personal positioning of oncology patients in palliative care: a mixed-methods study [Internet]. BMC Palliative Care. 2022 ; 21( 1): 1-13.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1186/s12904-022-00916-5
Vancouver
Silva HLM, Valério PHM, Barreira CRA, Peria FM. Personal positioning of oncology patients in palliative care: a mixed-methods study [Internet]. BMC Palliative Care. 2022 ; 21( 1): 1-13.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1186/s12904-022-00916-5
Artigo de periodico
Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms (2022)
Takei, Hisashi; Silva, Juan Luiz Coelho ; Leal, Cristina Tavares; Rocha, Adriana Queiroz Arantes; Bianco, Thiago Mantello ; Welner, Robert S.; Mishima, Yuta ; Kobayashi, Ikei S.; Mullally, Ann ; Lima, Keli Cristina de ; Machado Neto, João Agostinho ; Kobayashi, Susumu S. ; Pontes, Lorena Lobo De Figueiredo
Source: Cancer Science. Unidades: ICB, FMRP, FM
Subjects: FARMACOLOGIA, PROTEÍNAS PROTO-ONCOGÊNICAS, INIBIDORES DE ENZIMAS, MODELOS ANIMAIS DE DOENÇAS, FÁRMACOS, MEDICAMENTO, NEOPLASIAS, PROLIFERAÇÃO CELULAR, SOBREVIVÊNCIA CELULAR, CAMUNDONGOS, MUTAÇÃO, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAKEI, Hisashi et al. Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms. Cancer Science, v. 113, n. 2, p. 1-12, 2022Tradução . . Disponível em: https://doi.org/10.1111/cas.15210. Acesso em: 18 nov. 2024.
APA
Takei, H., Silva, J. L. C., Leal, C. T., Rocha, A. Q. A., Bianco, T. M., Welner, R. S., et al. (2022). Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms. Cancer Science, 113( 2), 1-12. doi:10.1111/cas.15210
NLM
Takei H, Silva JLC, Leal CT, Rocha AQA, Bianco TM, Welner RS, Mishima Y, Kobayashi IS, Mullally A, Lima KC de, Machado Neto JA, Kobayashi SS, Pontes LLDF. Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms [Internet]. Cancer Science. 2022 ; 113( 2): 1-12.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/cas.15210
Vancouver
Takei H, Silva JLC, Leal CT, Rocha AQA, Bianco TM, Welner RS, Mishima Y, Kobayashi IS, Mullally A, Lima KC de, Machado Neto JA, Kobayashi SS, Pontes LLDF. Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms [Internet]. Cancer Science. 2022 ; 113( 2): 1-12.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/cas.15210
Artigo de periodico
Histopathological criteria for paediatric adrenocortical carcinoma (2022)
Paschoalin, Victor Pereira; Tucci Júnior, Silvio ; Estevanato, Andrey Garcia; Tiraboschi, Ricardo Brianezi; Antonini, Sonir Roberto Rauber ; Muglia, Valdair Francisco ; Chahud, Fernando ; Mermejo, Lívia Mara; Bessa Junior, José de; Molina, Carlos Augusto Fernandes
Source: Hormone Research in Paediatrics. Unidade: FMRP
Subjects: CARCINOMA, NEOPLASIAS, CRIANÇAS, CÓRTEX ADRENAL, PROGNÓSTICO, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PASCHOALIN, Victor Pereira et al. Histopathological criteria for paediatric adrenocortical carcinoma. Hormone Research in Paediatrics, v. 95, n. 4, p. 347-353, 2022Tradução . . Disponível em: https://doi.org/10.1159/000524892. Acesso em: 18 nov. 2024.
APA
Paschoalin, V. P., Tucci Júnior, S., Estevanato, A. G., Tiraboschi, R. B., Antonini, S. R. R., Muglia, V. F., et al. (2022). Histopathological criteria for paediatric adrenocortical carcinoma. Hormone Research in Paediatrics, 95( 4), 347-353. doi:10.1159/000524892
NLM
Paschoalin VP, Tucci Júnior S, Estevanato AG, Tiraboschi RB, Antonini SRR, Muglia VF, Chahud F, Mermejo LM, Bessa Junior J de, Molina CAF. Histopathological criteria for paediatric adrenocortical carcinoma [Internet]. Hormone Research in Paediatrics. 2022 ; 95( 4): 347-353.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1159/000524892
Vancouver
Paschoalin VP, Tucci Júnior S, Estevanato AG, Tiraboschi RB, Antonini SRR, Muglia VF, Chahud F, Mermejo LM, Bessa Junior J de, Molina CAF. Histopathological criteria for paediatric adrenocortical carcinoma [Internet]. Hormone Research in Paediatrics. 2022 ; 95( 4): 347-353.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1159/000524892
Artigo de periodico
Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms (2021)
Cominal, Juçara Gastaldi; Cacemiro, Maira da Costa ; Berzoti-Coelho, Maria Gabriela ; Pereira, Illy Enne Gomes ; Frantz, Fabiani Gai ; Souto, Elizabeth Xisto; Covas, Dimas Tadeu; Figueiredo-Pontes, Lorena Lobo de; Oliveira, Maria Carolina; Malmegrim, Kelen Cristina Ribeiro ; Castro, Fabíola Attié de
Source: Frontiers in Oncology. Unidades: FCFRP, FMRP
Subjects: NEOVASCULARIZAÇÃO PATOLÓGICA, MEDULA ÓSSEA, CITOCINAS, INFLAMAÇÃO, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COMINAL, Juçara Gastaldi et al. Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Frontiers in Oncology, v. 11, p. 1-12 , 2021Tradução . . Disponível em: https://doi.org/10.3389/fonc.2021.665037. Acesso em: 18 nov. 2024.
APA
Cominal, J. G., Cacemiro, M. da C., Berzoti-Coelho, M. G., Pereira, I. E. G., Frantz, F. G., Souto, E. X., et al. (2021). Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Frontiers in Oncology, 11, 1-12 . doi:10.3389/fonc.2021.665037
NLM
Cominal JG, Cacemiro M da C, Berzoti-Coelho MG, Pereira IEG, Frantz FG, Souto EX, Covas DT, Figueiredo-Pontes LL de, Oliveira MC, Malmegrim KCR, Castro FA de. Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms [Internet]. Frontiers in Oncology. 2021 ; 11 1-12 .[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fonc.2021.665037
Vancouver
Cominal JG, Cacemiro M da C, Berzoti-Coelho MG, Pereira IEG, Frantz FG, Souto EX, Covas DT, Figueiredo-Pontes LL de, Oliveira MC, Malmegrim KCR, Castro FA de. Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms [Internet]. Frontiers in Oncology. 2021 ; 11 1-12 .[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fonc.2021.665037
Artigo de periodico
Predicting immunotherapy response through genomics (2021)
Cormedi, Marina Candido Visontai; Van Allen, Eliezer M; Colli, Leandro Machado
Source: Current Opinion in Genetics and Development. Unidade: FMRP
Subjects: ONCOGENES, BIOMARCADORES, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORMEDI, Marina Candido Visontai e VAN ALLEN, Eliezer M e COLLI, Leandro Machado. Predicting immunotherapy response through genomics. Current Opinion in Genetics and Development, v. 66, p. 1-9, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.gde.2020.11.004. Acesso em: 18 nov. 2024.
APA
Cormedi, M. C. V., Van Allen, E. M., & Colli, L. M. (2021). Predicting immunotherapy response through genomics. Current Opinion in Genetics and Development, 66, 1-9. doi:10.1016/j.gde.2020.11.004
NLM
Cormedi MCV, Van Allen EM, Colli LM. Predicting immunotherapy response through genomics [Internet]. Current Opinion in Genetics and Development. 2021 ; 66 1-9.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.gde.2020.11.004
Vancouver
Cormedi MCV, Van Allen EM, Colli LM. Predicting immunotherapy response through genomics [Internet]. Current Opinion in Genetics and Development. 2021 ; 66 1-9.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.gde.2020.11.004
Artigo de periodico
Strategies to enhance the therapeutic efficacy, applicability, and safety of genetically engineered immune cells (2021)
Lima, Sarah Caroline Gomes de ; Fantacini, Daianne Maciely Carvalho ; Batista, Laís de Castro; Silveira, Roberta Maraninchi ; Furtado, Izadora Peter; Rossetti, Rafaela; Brand, Heloisa ; Covas, Dimas Tadeu ; Souza, Lucas Eduardo Botelho de
Source: Critical Reviews in Immunology. Unidade: FMRP
Subjects: TERAPÊUTICA MÉDICA, NEOPLASIAS, GENÉTICA, CÉLULAS-TRONCO, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Sarah Caroline Gomes de et al. Strategies to enhance the therapeutic efficacy, applicability, and safety of genetically engineered immune cells. Critical Reviews in Immunology, v. 41, n. 1, p. 41-67, 2021Tradução . . Disponível em: https://doi.org/10.1615/CritRevImmunol.2021037437. Acesso em: 18 nov. 2024.
APA
Lima, S. C. G. de, Fantacini, D. M. C., Batista, L. de C., Silveira, R. M., Furtado, I. P., Rossetti, R., et al. (2021). Strategies to enhance the therapeutic efficacy, applicability, and safety of genetically engineered immune cells. Critical Reviews in Immunology, 41( 1), 41-67. doi:10.1615/CritRevImmunol.2021037437
NLM
Lima SCG de, Fantacini DMC, Batista L de C, Silveira RM, Furtado IP, Rossetti R, Brand H, Covas DT, Souza LEB de. Strategies to enhance the therapeutic efficacy, applicability, and safety of genetically engineered immune cells [Internet]. Critical Reviews in Immunology. 2021 ; 41( 1): 41-67.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1615/CritRevImmunol.2021037437
Vancouver
Lima SCG de, Fantacini DMC, Batista L de C, Silveira RM, Furtado IP, Rossetti R, Brand H, Covas DT, Souza LEB de. Strategies to enhance the therapeutic efficacy, applicability, and safety of genetically engineered immune cells [Internet]. Critical Reviews in Immunology. 2021 ; 41( 1): 41-67.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1615/CritRevImmunol.2021037437
Artigo de periodico
Associação Brasileira de Hematologia, Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. Review article: Cell therapy in solid tumors (2021)
Nardo, Mirella; Motta, Tatiane C.; Colli, Leandro Machado ; Avanzi, Mauro P.
Source: Hematology, Transfusion and Cell Therapy. Unidade: FMRP
Subjects: IMUNOTERAPIA, NEOPLASIAS, QUIMIOTERAPIA COMBINADA, SOBREVIDA, TUMOR CARCINOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NARDO, Mirella et al. Associação Brasileira de Hematologia, Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. Review article: Cell therapy in solid tumors. Hematology, Transfusion and Cell Therapy, v. 43, p. S78-S83, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2021.09.011. Acesso em: 18 nov. 2024.
APA
Nardo, M., Motta, T. C., Colli, L. M., & Avanzi, M. P. (2021). Associação Brasileira de Hematologia, Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. Review article: Cell therapy in solid tumors. Hematology, Transfusion and Cell Therapy, 43, S78-S83. doi:10.1016/j.htct.2021.09.011
NLM
Nardo M, Motta TC, Colli LM, Avanzi MP. Associação Brasileira de Hematologia, Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. Review article: Cell therapy in solid tumors [Internet]. Hematology, Transfusion and Cell Therapy. 2021 ; 43 S78-S83.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.htct.2021.09.011
Vancouver
Nardo M, Motta TC, Colli LM, Avanzi MP. Associação Brasileira de Hematologia, Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. Review article: Cell therapy in solid tumors [Internet]. Hematology, Transfusion and Cell Therapy. 2021 ; 43 S78-S83.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.htct.2021.09.011
Artigo de periodico
Pelvic floor muscles after prostate radiation therapy: morpho-functional assessment by magnetic resonance imaging, surface electromyography and digital anal palpation (2021)
Ribeiro, Aline Moreira; Nammur, Larissa Guerra; Mateus-Vasconcelos, Elaine Cristine Lemes; Ferreira, Cristine Homsi Jorge ; Muglia, Valdair Francisco ; Oliveira, Harley Francisco de
Source: International Brazilian Journal of Urology. Unidades: FMRP, FORP
Subjects: SOALHO PÉLVICO, NEOPLASIAS, RADIOTERAPIA, NEOPLASIAS PROSTÁTICAS, RESSONÂNCIA MAGNÉTICA NUCLEAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Aline Moreira et al. Pelvic floor muscles after prostate radiation therapy: morpho-functional assessment by magnetic resonance imaging, surface electromyography and digital anal palpation. International Brazilian Journal of Urology, v. 47, n. 1, p. 120-130, 2021Tradução . . Disponível em: https://doi.org/10.1590/S1677-5538.IBJU.2019.0765. Acesso em: 18 nov. 2024.
APA
Ribeiro, A. M., Nammur, L. G., Mateus-Vasconcelos, E. C. L., Ferreira, C. H. J., Muglia, V. F., & Oliveira, H. F. de. (2021). Pelvic floor muscles after prostate radiation therapy: morpho-functional assessment by magnetic resonance imaging, surface electromyography and digital anal palpation. International Brazilian Journal of Urology, 47( 1), 120-130. doi:10.1590/S1677-5538.IBJU.2019.0765
NLM
Ribeiro AM, Nammur LG, Mateus-Vasconcelos ECL, Ferreira CHJ, Muglia VF, Oliveira HF de. Pelvic floor muscles after prostate radiation therapy: morpho-functional assessment by magnetic resonance imaging, surface electromyography and digital anal palpation [Internet]. International Brazilian Journal of Urology. 2021 ; 47( 1): 120-130.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1590/S1677-5538.IBJU.2019.0765
Vancouver
Ribeiro AM, Nammur LG, Mateus-Vasconcelos ECL, Ferreira CHJ, Muglia VF, Oliveira HF de. Pelvic floor muscles after prostate radiation therapy: morpho-functional assessment by magnetic resonance imaging, surface electromyography and digital anal palpation [Internet]. International Brazilian Journal of Urology. 2021 ; 47( 1): 120-130.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1590/S1677-5538.IBJU.2019.0765
Artigo de periodico
Outcomes and survival of spinal metastasis with epidural compression (2021)
Pinheiro, Romulo Pedroza ; Candido, Priscila Barile Marchi; Peria, Fernanda Maris ; Costa, Herton Rodrigo Tavares ; Defino, Helton Luiz Aparecido
Source: Journal of Craniovertebral Junction and Spine. Unidade: FMRP
Subjects: NEOPLASIAS, METÁSTASE NEOPLÁSICA, PROCEDIMENTOS CIRÚRGICOS OPERATÓRIOS, COLUNA VERTEBRAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINHEIRO, Romulo Pedroza et al. Outcomes and survival of spinal metastasis with epidural compression. Journal of Craniovertebral Junction and Spine, v. 12, n. 3, p. 287-293, 2021Tradução . . Disponível em: https://doi.org/10.4103/jcvjs.jcvjs_33_21. Acesso em: 18 nov. 2024.
APA
Pinheiro, R. P., Candido, P. B. M., Peria, F. M., Costa, H. R. T., & Defino, H. L. A. (2021). Outcomes and survival of spinal metastasis with epidural compression. Journal of Craniovertebral Junction and Spine, 12( 3), 287-293. doi:10.4103/jcvjs.jcvjs_33_21
NLM
Pinheiro RP, Candido PBM, Peria FM, Costa HRT, Defino HLA. Outcomes and survival of spinal metastasis with epidural compression [Internet]. Journal of Craniovertebral Junction and Spine. 2021 ; 12( 3): 287-293.[citado 2024 nov. 18 ] Available from: https://doi.org/10.4103/jcvjs.jcvjs_33_21
Vancouver
Pinheiro RP, Candido PBM, Peria FM, Costa HRT, Defino HLA. Outcomes and survival of spinal metastasis with epidural compression [Internet]. Journal of Craniovertebral Junction and Spine. 2021 ; 12( 3): 287-293.[citado 2024 nov. 18 ] Available from: https://doi.org/10.4103/jcvjs.jcvjs_33_21
Trabalho de evento-resumo periodico
Non-viral engineering of CAR-NK cells for cancer immunotherapy (2020)
Gomes, Kauan Ribeiro de Sena; Silvestre, Renata Nacasaki; Azevedo, Júlia Teixeira Cottas de; Swiech, Kamilla ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Covas, Dimas Tadeu; Picanço-Castro, Virgínia
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HemoPlay 2020). Unidades: FCFRP, FMRP
Subjects: LINFÓCITOS, CÉLULAS, IMUNOTERAPIA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Kauan Ribeiro de Sena et al. Non-viral engineering of CAR-NK cells for cancer immunotherapy. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.706. Acesso em: 18 nov. 2024. , 2020
APA
Gomes, K. R. de S., Silvestre, R. N., Azevedo, J. T. C. de, Swiech, K., Farias, K. C. R. M. de, Covas, D. T., & Picanço-Castro, V. (2020). Non-viral engineering of CAR-NK cells for cancer immunotherapy. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.706
NLM
Gomes KR de S, Silvestre RN, Azevedo JTC de, Swiech K, Farias KCRM de, Covas DT, Picanço-Castro V. Non-viral engineering of CAR-NK cells for cancer immunotherapy [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S420.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.htct.2020.10.706
Vancouver
Gomes KR de S, Silvestre RN, Azevedo JTC de, Swiech K, Farias KCRM de, Covas DT, Picanço-Castro V. Non-viral engineering of CAR-NK cells for cancer immunotherapy [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S420.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.htct.2020.10.706
Trabalho de evento-resumo periodico
Optimizing intracellular signaling domains for CAR-NK cells (2020)
Azevedo, Júlia Teixeira Cottas de; Silvestre, Renata Nacasaki; Pessoni, André Moreira ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Covas, Dimas Tadeu; Picanço-Castro, Virgínia
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HemoPlay 2020). Unidades: FCFRP, FMRP
Subjects: SISTEMA IMUNE, NEOPLASIAS, PROLIFERAÇÃO CELULAR, LEUCEMIA, LINFOMA, TRANSDUÇÃO DE SINAL CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AZEVEDO, Júlia Teixeira Cottas de et al. Optimizing intracellular signaling domains for CAR-NK cells. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.710. Acesso em: 18 nov. 2024. , 2020
APA
Azevedo, J. T. C. de, Silvestre, R. N., Pessoni, A. M., Farias, K. C. R. M. de, Covas, D. T., & Picanço-Castro, V. (2020). Optimizing intracellular signaling domains for CAR-NK cells. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.710
NLM
Azevedo JTC de, Silvestre RN, Pessoni AM, Farias KCRM de, Covas DT, Picanço-Castro V. Optimizing intracellular signaling domains for CAR-NK cells [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S422-S423.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.htct.2020.10.710
Vancouver
Azevedo JTC de, Silvestre RN, Pessoni AM, Farias KCRM de, Covas DT, Picanço-Castro V. Optimizing intracellular signaling domains for CAR-NK cells [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S422-S423.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.htct.2020.10.710
Trabalho de evento-resumo periodico
Arachidonic acid (aa)-derived lipid mediators are increased in the bone marrow plasma from polycythemia vera and essential thrombocythemia patients (2020)
Cacemiro, Maira da Costa ; Cominal, Juçara Gastaldi ; Pontes, Lorena Lobo de Figueiredo ; Sorgi, Carlos Arterio ; Faccioli, Lucia Helena ; Castro, Fabíola Attié de
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular - HemoPlay. Unidades: FMRP, FFCLRP, FCFRP
Subjects: NEOPLASIAS, MEDULA ÓSSEA, POLICITEMIA, TROMBOCITOSE, ONCOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CACEMIRO, Maira da Costa et al. Arachidonic acid (aa)-derived lipid mediators are increased in the bone marrow plasma from polycythemia vera and essential thrombocythemia patients. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.197. Acesso em: 18 nov. 2024. , 2020
APA
Cacemiro, M. da C., Cominal, J. G., Pontes, L. L. de F., Sorgi, C. A., Faccioli, L. H., & Castro, F. A. de. (2020). Arachidonic acid (aa)-derived lipid mediators are increased in the bone marrow plasma from polycythemia vera and essential thrombocythemia patients. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.197
NLM
Cacemiro M da C, Cominal JG, Pontes LL de F, Sorgi CA, Faccioli LH, Castro FA de. Arachidonic acid (aa)-derived lipid mediators are increased in the bone marrow plasma from polycythemia vera and essential thrombocythemia patients [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S117.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.htct.2020.10.197
Vancouver
Cacemiro M da C, Cominal JG, Pontes LL de F, Sorgi CA, Faccioli LH, Castro FA de. Arachidonic acid (aa)-derived lipid mediators are increased in the bone marrow plasma from polycythemia vera and essential thrombocythemia patients [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S117.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.htct.2020.10.197
Artigo de periodico-carta/editorial
Co-occurrence of BCR–ABL1-positive chronic myeloid leukaemia and CALR-mutated essential thrombocythaemia [Carta] (2020)
Costa, Victor E. F.; Oliveira, Rafael D.; Traina, Fabiola ; Chahud, Fernando ; Palma, Leonardo Carvalho; Pontes, Lorena Lobo de Figueiredo
Source: British Journal of Haematology. Unidade: FMRP
Subjects: LEUCEMIA MIELOIDE, TROMBOCITOSE, MUTAÇÃO GENÉTICA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Victor E. F. et al. Co-occurrence of BCR–ABL1-positive chronic myeloid leukaemia and CALR-mutated essential thrombocythaemia [Carta]. British Journal of Haematology. Chichester: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1111/bjh.16274. Acesso em: 18 nov. 2024. , 2020
APA
Costa, V. E. F., Oliveira, R. D., Traina, F., Chahud, F., Palma, L. C., & Pontes, L. L. de F. (2020). Co-occurrence of BCR–ABL1-positive chronic myeloid leukaemia and CALR-mutated essential thrombocythaemia [Carta]. British Journal of Haematology. Chichester: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1111/bjh.16274
NLM
Costa VEF, Oliveira RD, Traina F, Chahud F, Palma LC, Pontes LL de F. Co-occurrence of BCR–ABL1-positive chronic myeloid leukaemia and CALR-mutated essential thrombocythaemia [Carta] [Internet]. British Journal of Haematology. 2020 ; 188( 3): e21-e23.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/bjh.16274
Vancouver
Costa VEF, Oliveira RD, Traina F, Chahud F, Palma LC, Pontes LL de F. Co-occurrence of BCR–ABL1-positive chronic myeloid leukaemia and CALR-mutated essential thrombocythaemia [Carta] [Internet]. British Journal of Haematology. 2020 ; 188( 3): e21-e23.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/bjh.16274
Artigo de periodico
Reversine exerts cytotoxic effects through multiple cell death mechanisms in acute lymphoblastic leukemia (2020)
Carlos, Jorge Antonio Elias Godoy; Lima, Keli ; Silva, Juan Luiz Coelho da ; Paiva, Raquel de Melo Alves ; Moreno, Natália Cestari ; Vicari, Hugo Passos ; Santos, Fábio Pires de Souza ; Hamerschlak, Nelson ; Traina, Fabiola ; Costa-Lotufo, Letícia Veras ; Machado Neto, João Agostinho
Source: Cellular Oncology (Dordrecht, 2011). Unidades: FMRP, ICB, IQ, FM
Subjects: FARMACOLOGIA, APOPTOSE, LEUCEMIA MIELOIDE AGUDA, MITOSE, NEOPLASIAS, PURINAS, EXPRESSÃO GÊNICA, LINFÓCITOS, PROLIFERAÇÃO CELULAR, DANO AO DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARLOS, Jorge Antonio Elias Godoy et al. Reversine exerts cytotoxic effects through multiple cell death mechanisms in acute lymphoblastic leukemia. Cellular Oncology (Dordrecht, 2011), v. 43, n. 6, p. 1191-1201, 2020Tradução . . Disponível em: https://doi.org/10.1007/s13402-020-00551-3. Acesso em: 18 nov. 2024.
APA
Carlos, J. A. E. G., Lima, K., Silva, J. L. C. da, Paiva, R. de M. A., Moreno, N. C., Vicari, H. P., et al. (2020). Reversine exerts cytotoxic effects through multiple cell death mechanisms in acute lymphoblastic leukemia. Cellular Oncology (Dordrecht, 2011), 43( 6), 1191-1201. doi:10.1007/s13402-020-00551-3
NLM
Carlos JAEG, Lima K, Silva JLC da, Paiva R de MA, Moreno NC, Vicari HP, Santos FP de S, Hamerschlak N, Traina F, Costa-Lotufo LV, Machado Neto JA. Reversine exerts cytotoxic effects through multiple cell death mechanisms in acute lymphoblastic leukemia [Internet]. Cellular Oncology (Dordrecht, 2011). 2020 ; 43( 6): 1191-1201.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s13402-020-00551-3
Vancouver
Carlos JAEG, Lima K, Silva JLC da, Paiva R de MA, Moreno NC, Vicari HP, Santos FP de S, Hamerschlak N, Traina F, Costa-Lotufo LV, Machado Neto JA. Reversine exerts cytotoxic effects through multiple cell death mechanisms in acute lymphoblastic leukemia [Internet]. Cellular Oncology (Dordrecht, 2011). 2020 ; 43( 6): 1191-1201.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s13402-020-00551-3
Trabalho de evento-resumo periodico
Irs1S57X heterozygous mutant mice display normal hematopoiesis and phenotypic features, while homozygous knockout exhibit high fetal or postnatal lethality (2020)
Fenerich, Bruna Alves ; Fernandes, Jaqueline Cristina; Silva, Cleide Lúcia Araújo; Coelho-Silva, Juan Luiz; Silva, Antônio Bruno Alves; Fonseca, Natasha Peixoto; Machado Neto, João Agostinho ; Traina, Fabiola
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidades: ICB, FMRP
Subjects: HEMATOPOESE, TRANSTORNOS MIELOPROLIFERATIVOS, NEOPLASIAS, GENES, FENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FENERICH, Bruna Alves et al. Irs1S57X heterozygous mutant mice display normal hematopoiesis and phenotypic features, while homozygous knockout exhibit high fetal or postnatal lethality. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2020-139422. Acesso em: 18 nov. 2024. , 2020
APA
Fenerich, B. A., Fernandes, J. C., Silva, C. L. A., Coelho-Silva, J. L., Silva, A. B. A., Fonseca, N. P., et al. (2020). Irs1S57X heterozygous mutant mice display normal hematopoiesis and phenotypic features, while homozygous knockout exhibit high fetal or postnatal lethality. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1182/blood-2020-139422
NLM
Fenerich BA, Fernandes JC, Silva CLA, Coelho-Silva JL, Silva ABA, Fonseca NP, Machado Neto JA, Traina F. Irs1S57X heterozygous mutant mice display normal hematopoiesis and phenotypic features, while homozygous knockout exhibit high fetal or postnatal lethality [Internet]. Blood. 2020 ; 136 [3] .[citado 2024 nov. 18 ] Available from: https://doi.org/10.1182/blood-2020-139422
Vancouver
Fenerich BA, Fernandes JC, Silva CLA, Coelho-Silva JL, Silva ABA, Fonseca NP, Machado Neto JA, Traina F. Irs1S57X heterozygous mutant mice display normal hematopoiesis and phenotypic features, while homozygous knockout exhibit high fetal or postnatal lethality [Internet]. Blood. 2020 ; 136 [3] .[citado 2024 nov. 18 ] Available from: https://doi.org/10.1182/blood-2020-139422
Trabalho de evento-resumo periodico
Optimization of a process for high-yield lentiviral vector production applied to car-t cell generation (2020)
Fantacini, Daianne Maciely Carvalho; Lima, Sarah Caroline Gomes de ; Brand, Heloisa; Batista, L. C.; Cunha, R.; Covas, Dimas Tadeu ; Souza, Lucas Eduardo Botelho de
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular - HemoPlay. Unidade: FMRP
Subjects: CÉLULAS-TRONCO, NEOPLASIAS, LINFÓCITOS, LENTIVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FANTACINI, Daianne Maciely Carvalho et al. Optimization of a process for high-yield lentiviral vector production applied to car-t cell generation. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.709. Acesso em: 18 nov. 2024. , 2020
APA
Fantacini, D. M. C., Lima, S. C. G. de, Brand, H., Batista, L. C., Cunha, R., Covas, D. T., & Souza, L. E. B. de. (2020). Optimization of a process for high-yield lentiviral vector production applied to car-t cell generation. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.709
NLM
Fantacini DMC, Lima SCG de, Brand H, Batista LC, Cunha R, Covas DT, Souza LEB de. Optimization of a process for high-yield lentiviral vector production applied to car-t cell generation [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 421-422.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.htct.2020.10.709
Vancouver
Fantacini DMC, Lima SCG de, Brand H, Batista LC, Cunha R, Covas DT, Souza LEB de. Optimization of a process for high-yield lentiviral vector production applied to car-t cell generation [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 421-422.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.htct.2020.10.709

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration